Analysts tracking avdl stock forecast are highlighting the potential for a 12% upside over the next 3 months, contingent on favorable analyst ratings and sustained sector momentum. In the previous quarter of 2024-06-30, Avadel Pharmaceuticals PLC's ( NASDAQ:AVDL ) actual revenue was $41.50 million, which beat analysts' revenue expectations of $37.535 million by 10.57%. Avadel Pharmaceuticals PLC's ( NASDAQ:AVDL ) actual earnings were -$0.14 per share, which beat analysts' earnings expectations of -$0.156 per share by 10.26%. After releasing the results, Avadel Pharmaceuticals PLC ( NASDAQ:AVDL ) was down by -2.24% in one day. ON watch-list for sustained rally Bullish reversal on indicators Volume-weighted average price metrics in the avdl stock forecast show a stabilization pattern, suggesting potential accumulation phase before the next major price move.